Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00841867 · ClinicalTrials.gov registry record
The Role of Pulsatile Insulin Secretion (A Study Investigating the Effects of Partial Pacreatectomy on Glucose Metabolism)
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 24
- Enrollment target
NCT00841867: Completed study, sponsored by University of California, Los Angeles.
NCT00841867 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00841867 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to examine changes in sugar metabolism that may occur in subjects who have previously had part of their pancreas removed due to a benign lesion.
Interventions
- PROCEDURE All subjects will undergo a 120 minute Oral Glucose Tolerance Test at study visit 2.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-10 |
What the finished NCT00841867 record still lists
NCT00841867 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which All subjects will undergo a 120 minute Oral Glucose Tolerance Test at study visit 2. is the first listed.
NCT00841867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00841867 about?
NCT00841867 is a clinical study titled "The Role of Pulsatile Insulin Secretion (A Study Investigating the Effects of Partial Pacreatectomy on Glucose Metabolism)". The purpose of this study is to examine changes in sugar metabolism that may occur in subjects who have previously had part of their pancreas removed due to a benign lesion.
What is the current status of trial NCT00841867?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2008-12. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00841867?
The interventions under investigation include: All subjects will undergo a 120 minute Oral Glucose Tolerance Test at study visit 2. (PROCEDURE).
Who is sponsoring clinical trial NCT00841867?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia